CLOs on the Move

Gentle Path Press

www.gentlepath.com

 
Gentle Path Press is a Carefree, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Rx America

Rx America is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Rx America is based in Salt Lake City, UT. You can find more information on Rx America at www.rxamerica.com

Focus Health

Focus Health is a Kearney, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Centralized Research Services

Centralized Research Services is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Subconscious Training Corporation

Subconscious Training Corporation is a Pompano Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.